BRIGHAM INC

Forschungsprojekte

• Precision drug REPurpOsing For EUrope and the world Here we, a group of long-standing collaborators in innovative drug repurposing, propose to build REPO4EU, a c…
• Metabolic imprinting of Th17 cells in disease pathogenesis Autoimmune diseases affect an estimated 3-9% of the population and cause major personal and socio-economic co…
• Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brai…
• Targeting the circadian clock in personalized disease prevention Virtually every cell of our body follows the 24-hr ‘circadian’ rhythm of a hypothalamic master pacemaker that…
• VoluFaTE: Volumetric programming of cells to control the fate and function of engineered tissues Engineering living tissues is expected to revolutionize pharmacological screenings, fundamental biological st…